Markets

CSL’s sweeping restructure has hammered its share price, but the Allan Gray chief investment officer says the shift may finally make the biotech a buy.

Global CEO Robert Thomson said he and OpenAI's Sam Altman are both "deeply into property".

The Macquarie Capital global strategist believes governments are not contemplating the right policies to deal with the huge impact AI will have on labour.